A Presenilin 1 Mutation Associated with Familial Frontotemporal Dementia Inhibits γ-Secretase Cleavage of APP and Notch
- 31 March 2002
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 9 (2), 269-273
- https://doi.org/10.1006/nbdi.2001.0473
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Screening for PS1 mutations in a referral-based series of AD casesNeurology, 2001
- Presenilins as therapeutic targets for the treatment of Alzheimer's diseaseTrends in Molecular Medicine, 2001
- Dementia with prominent frontotemporal features associated with L113P presenilin 1 mutationNeurology, 2000
- Presenilin 1 Regulates Pharmacologically Distinct γ-Secretase ActivitiesJournal of Biological Chemistry, 2000
- γ-Secretase, Evidence for Multiple Proteolytic Activities and Influence of Membrane Positioning of Substrate on Generation of Amyloid β Peptides of Varying LengthJournal of Biological Chemistry, 1999
- Increased Aβ42(43) from cell lines expressing presenilin 1 mutationsAnnals of Neurology, 1998
- Amyloid, the presenilins and Alzheimer's diseaseTrends in Neurosciences, 1997
- Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1Nature, 1996
- Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's diseaseNature Medicine, 1996
- Deposition of beta/A4 immunoreactivity and neuronal pathology in transgenic mice expressing the carboxyl-terminal fragment of the Alzheimer amyloid precursor in the brain.Proceedings of the National Academy of Sciences, 1992